• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Revisiting Once Again Steroids for the Treatment of Acute Kawasaki Disease.

作者信息

Burns Jane C

机构信息

Department of Pediatrics UCSD School of Medicine and Rady Children's Hospital San Diego CA.

出版信息

J Am Heart Assoc. 2020 Sep;9(17):e018300. doi: 10.1161/JAHA.120.018300. Epub 2020 Aug 19.

DOI:10.1161/JAHA.120.018300
PMID:32811264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7660753/
Abstract
摘要

相似文献

1
Revisiting Once Again Steroids for the Treatment of Acute Kawasaki Disease.再次探讨类固醇治疗急性川崎病
J Am Heart Assoc. 2020 Sep;9(17):e018300. doi: 10.1161/JAHA.120.018300. Epub 2020 Aug 19.
2
Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease.重新审视类固醇和阿司匹林在急性川崎病治疗中的作用。
Curr Opin Rheumatol. 2017 Sep;29(5):547-552. doi: 10.1097/BOR.0000000000000425.
3
Kawasaki disease: part II. Complications and treatment.川崎病：第二部分。并发症和治疗。
J Am Acad Dermatol. 2013 Oct;69(4):513.e1-8; quiz 521-2. doi: 10.1016/j.jaad.2013.06.040.
4
Kawasaki disease.川崎病。
Pediatr Clin North Am. 2012 Apr;59(2):425-45. doi: 10.1016/j.pcl.2012.03.009.
5
Acute cardiac valvular involvement in Kawasaki Disease.
Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S140. Epub 2011 May 11.
6
Revisiting steroids in the primary treatment of acute Kawasaki disease.重新审视类固醇在急性川崎病初始治疗中的应用
J Pediatr. 2006 Sep;149(3):291-2. doi: 10.1016/j.jpeds.2006.07.016.
7
An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes.川崎病最新进展II：临床特征、诊断、治疗及预后
J Paediatr Child Health. 2013 Aug;49(8):614-23. doi: 10.1111/jpc.12221. Epub 2013 May 7.
8
Intravenous immunoglobulin plus corticosteroids prevent coronary artery abnormalities in Kawasaki disease.静脉注射免疫球蛋白加皮质类固醇可预防川崎病的冠状动脉异常。
Evid Based Med. 2013 Dec;18(6):217-8. doi: 10.1136/eb-2013-101264. Epub 2013 Apr 5.
9
Pharmacological therapy for patients with Kawasaki disease.川崎病患者的药物治疗
Paediatr Drugs. 2001;3(9):649-60. doi: 10.2165/00128072-200103090-00003.
10
Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.川崎病静脉注射免疫球蛋白抵抗的生物标志物与冠状动脉病变。
World J Pediatr. 2019 Apr;15(2):168-175. doi: 10.1007/s12519-019-00234-6. Epub 2019 Feb 27.

引用本文的文献

1
The protective role of steroids on coronary arteries in the acute phase of Kawasaki disease for high risk patients: a retrospective study.类固醇对川崎病急性期高危患者冠状动脉的保护作用：一项回顾性研究。
Front Pediatr. 2025 Aug 28;13:1636339. doi: 10.3389/fped.2025.1636339. eCollection 2025.

本文引用的文献

1
Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High-Risk Patients With Kawasaki Disease.皮质类固醇添加至初始静脉注射免疫球蛋白治疗预防高危川崎病患者冠状动脉异常。
J Am Heart Assoc. 2020 Sep;9(17):e015308. doi: 10.1161/JAHA.119.015308. Epub 2020 Aug 19.
2
Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population.北美人群川崎病冠状动脉瘤风险模型的建立与验证。
J Am Heart Assoc. 2019 Jun 4;8(11):e011319. doi: 10.1161/JAHA.118.011319.
3
Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.川崎病合并冠状动脉瘤患儿的强化治疗。
Pediatrics. 2019 Jun;143(6). doi: 10.1542/peds.2018-3341. Epub 2019 May 2.
4
Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.亚洲风险评分系统无法预测意大利队列川崎病患者静脉注射免疫球蛋白耐药和冠状动脉病变。
Eur J Pediatr. 2019 Mar;178(3):315-322. doi: 10.1007/s00431-018-3297-5. Epub 2018 Nov 29.
5
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.静脉注射免疫球蛋白联合泼尼松龙治疗川崎病的疗效和安全性（Post RAISE）：一项多中心前瞻性队列研究。
Lancet Child Adolesc Health. 2018 Dec;2(12):855-862. doi: 10.1016/S2352-4642(18)30293-1. Epub 2018 Oct 16.
6
Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline Scores.北美某中心对川崎病患者冠状动脉瘤的预测：基线评分评估
J Am Heart Assoc. 2017 May 31;6(6):e005378. doi: 10.1161/JAHA.116.005378.
7
Preventing coronary artery abnormalities: a need for earlier diagnosis and treatment of Kawasaki disease.预防冠状动脉异常：川崎病早期诊断和治疗的必要性。
Pediatr Infect Dis J. 2012 Dec;31(12):1217-20. doi: 10.1097/INF.0b013e318266bcf9.
8
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.免疫球蛋白联合泼尼松龙预防重症川崎病冠状动脉异常的疗效（RAISE 研究）：一项随机、开放标签、盲终点试验。
Lancet. 2012 Apr 28;379(9826):1613-20. doi: 10.1016/S0140-6736(11)61930-2. Epub 2012 Mar 8.
9
Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance.川崎病静脉注射免疫球蛋白抵抗风险评分系统的评估。
J Pediatr. 2011 May;158(5):831-835.e3. doi: 10.1016/j.jpeds.2010.10.031. Epub 2010 Dec 18.
10
Resistance to intravenous immunoglobulin in children with Kawasaki disease.川崎病患儿对静脉注射免疫球蛋白的耐药性。
J Pediatr. 2008 Jul;153(1):117-21. doi: 10.1016/j.jpeds.2007.12.021. Epub 2008 Mar 4.